|
MDH1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.440170E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.273840E-01 |
| Normal-vs-Stage2 |
7.070300E-02 |
| Normal-vs-Stage3 |
7.608600E-01 |
| Normal-vs-Stage4 |
8.911200E-01 |
| Stage1-vs-Stage2 |
2.444200E-01 |
| Stage1-vs-Stage3 |
2.159200E-01 |
| Stage1-vs-Stage4 |
2.335000E-01 |
| Stage2-vs-Stage3 |
9.477900E-02 |
| Stage2-vs-Stage4 |
8.422100E-02 |
| Stage3-vs-Stage4 |
6.999800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.636400E-01 |
| Normal-vs-AfricanAmerican |
4.402600E-01 |
| Normal-vs-Asian |
6.231400E-01 |
| Caucasian-vs-AfricanAmerican |
5.651200E-01 |
| Caucasian-vs-Asian |
8.009600E-01 |
| AfricanAmerican-vs-Asian |
7.485000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.342000E-01 |
| Normal-vs-Female |
1.177400E-01 |
| Male-vs-Female |
5.497200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.869770E-01 |
| Normal-vs-Age(41-60Yrs) |
4.381600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.112030E-01 |
| Normal-vs-Age(81-100Yrs) |
7.920200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.462400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.706200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.790200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.652600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.387200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.613200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.315400E-01 |
| Classical-VS-Follicular |
1.584430E-03 |
| Classical-VS-Other |
7.651400E-01 |
| Classical-VS-Normal |
7.674800E-01 |
| Tall-VS-Follicular |
1.192190E-01 |
| Tall-VS-Other |
3.901200E-01 |
| Tall-VS-Normal |
1.569990E-01 |
| Follicular-VS-Other |
2.472200E-01 |
| Follicular-VS-Normal |
2.098500E-03 |
| Other-VS-Normal |
7.997400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.485570E-01 |
| Normal-vs-N1 |
1.728640E-01 |
| N0-vs-N1 |
1.731620E-02 |
|
|
